中国医药品牌怎么样 申请店铺

我要投票 中国医药在化学药物行业中的票数:139 更新时间:2025-03-13
中国医药是哪个国家的品牌?「中国医药」是 中国医药集团有限公司 旗下著名品牌。该品牌发源于北京市,由创始人佘鲁林在1987-03-26期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力中国医药品牌出海!通过在本页面挂载中国医药品牌的产品链接和联系邮箱,可以提高中国医药产品曝光!跨境电商爆单神器,目前只要100元/年哦~

中国医药怎么样

中国医药健康产业股份有限公司是在上海证券交易所挂牌的国有控股上市公司(股票简称:中国医药;证券代码:600056),其控股股东为中央骨干企业中国通用技术(集团)控股有限公司。公司秉承“关爱生命、追求卓越”的核心理念,致力于医药产业发展和人类健康事业,努力打造中国医药领域的旗舰企业。

公司已经建立起了以国际贸易为引领、以医药工业为支撑、以医药商业为纽带的科工贸一体化产业格局,产业形态涉及研发、种植加工、生产、分销、物流、进出口贸易、学术推广、技术服务等全产业链条。

在医药研发生产领域,公司拥有两家博士后科研工作站及一大批高素质研发专家,曾获国家科技进步二等奖;公司拥有国内领先的化学原料药研发生产平台,国内先进的特色化学药、现代中药研发生产平台,在抗感染类、抗病毒类药物的研发生产及甘草等药材及其制品的种植加工领域处于领先地位。

在国际贸易领域,作为医药行业进出口领域传统专业主渠道,公司始终保持着领先地位,且在政府项目业务领域具备传统实力和特色优势。天然药物贸易业务坚持全产业链专业化发展模式,有机整合天然药物种植、仓储、加工、销售等产业链环节,在行业内居于领先地位。医药化工贸易业务经营范围涵盖化学原料及制剂、生物及血液制品各品规、全领域,可为客户提供一流的医药化工贸易集成服务。医疗器械贸易业务致力于为客户提供全过程项目集成化服务,并与世界各著名医疗器械生产商建立了稳固的合作关系,在进口和分销领域处于国内领先地位。健康领域大宗商品业务涉及保健食品原料、大宗农产品、精细化工原材料等,在一些重点商品进出口贸易领域有较高知名度。

在国内医药商业领域,公司已逐步建立起以高端、特色产品为核心,具有产业价值链整合协同优势的医药商业体系。已形成以北京、广东、江西、河南、河北、湖北、新疆为重点,覆盖全国的营销网络体系,并在所在区域具有较高的知名度和品牌影响力。公司建有大型物流中心,具备完善的经营资质,可为广大合作伙伴提供全方位的增值服务。

面向未来,中国医药着力在重点产品领域建立横跨国内和国际两个市场的营销网络,聚焦现代中药、特色化学制剂和生物制药等核心产业领域,打造集研发、生产、销售、服务于一体的产业链,努力将公司发展成为一家在国内医药行业中具有重要地位、在国际市场具有较强竞争力和品牌影响力的科工贸一体化大型医药企业集团。



China Pharmaceutical and Health Industry Co., Ltd. is a state-owned holding listed company (stock abbreviation: China Pharmaceutical; securities code: 600056) listed on Shanghai Stock Exchange. Its controlling shareholder is China General Technology (Group) Holding Co., Ltd., a central backbone enterprise. Adhering to the core concept of "caring for life and pursuing excellence", the company is committed to the development of pharmaceutical industry and human health, striving to build a flagship enterprise in the field of Chinese medicine. The company has established an integrated industrial pattern of science, industry and trade with international trade as the guide, pharmaceutical industry as the support and pharmaceutical business as the link. The industrial pattern involves the whole industrial chain of R & D, planting and processing, production, distribution, logistics, import and export trade, academic promotion, technical services, etc. In the field of pharmaceutical R & D and production, the company has two postdoctoral research stations and a large number of high-quality R & D experts, who have won the second prize of national science and technology progress; the company has a leading R & D and production platform for chemical raw materials, domestic advanced characteristic chemical drugs, modern Chinese medicine research and development production platform, in the R & D and production of anti infective and anti viral drugs, licorice and other medicinal materials The planting and processing field of products is in a leading position. In the field of international trade, as the traditional professional main channel in the field of import and export of pharmaceutical industry, the company has always maintained a leading position, and has traditional strength and characteristic advantages in the field of government project business. The natural medicine trade business adheres to the whole industrial chain specialized development mode, organically integrates the natural medicine planting, storage, processing, sales and other industrial chain links, and takes the leading position in the industry. The business scope of pharmaceutical and chemical trade covers chemical raw materials and preparations, biological and blood products, and all fields. It can provide customers with first-class integrated pharmaceutical and chemical trade services. The medical device trade business is committed to providing customers with the whole process of project integration services, and has established a solid cooperative relationship with the world's famous medical device manufacturers, and is in the leading position in the field of import and distribution in China. The bulk commodity business in the health sector involves health food raw materials, bulk agricultural products, fine chemical raw materials, etc., and has a high reputation in the import and export trade of some key commodities. In the field of domestic pharmaceutical business, the company has gradually established a pharmaceutical business system with high-end, characteristic products as the core and industrial value chain integration and coordination advantages. It has formed a marketing network system focusing on Beijing, Guangdong, Jiangxi, Henan, Hebei, Hubei and Xinjiang, covering the whole country, and has a high visibility and brand influence in its region. The company has built a large-scale logistics center with perfect business qualification, which can provide all-round value-added services for the vast number of partners. Facing the future, China Pharmaceutical focuses on establishing a marketing network across the domestic and international markets in key product areas, focusing on core industries such as modern Chinese medicine, characteristic chemicals and biopharmaceuticals, creating an industrial chain integrating R & D, production, sales and service, and striving to develop the company into a company with an important position in the domestic pharmaceutical industry and in the international market A large pharmaceutical enterprise group with strong competitiveness and brand influence.

本文链接: https://brand.waitui.com/755334abf.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

扫地机器人制造商iRobot发出持续经营风险警告、考虑潜在出售

扫地机器人制造商iRobot当地时间3月12日发布财报显示,公司2024年四季度销售额同比减少44%至1.72亿美元,最终亏损为7710万美元,高于去年同期的6359万美元。iRobot在收益报告中表示,鉴于消费者需求、竞争、宏观经济条件和关税政策等方面存在不确定性,以及其对公司财务状况的影响,“人们对iRobot自发布2024年合并财报之日起至少12个月内继续经营的能力存在重大疑问”。声明称,iRobot董事会已启动正式的战略审查,以评估多项替代方案,包括但不限于为公司债务再融资以及探索潜在出售或战略交易。(界面)

2小时前

恒生科技指数跌幅扩大至2%

36氪获悉,截至发稿,恒生科技指数跌幅扩大至2%,同程旅行跌近9%,快手跌超4%。

2小时前

阿里正式推出AI旗舰应用,新夸克发布“AI超级框”

36氪获悉,3月13日,阿里巴巴宣布推出AI旗舰应用——新夸克。新夸克基于阿里通义领先的推理及多模态大模型,全面升级为一个无边界的“AI超级框”。阿里巴巴表示,未来通义系列模型的最新成果都将第一时间接入夸克。新夸克将告别传统搜索,升级为一个All in One的“AI超级框”,满足用户工作、学习、生活的各类AI需求。

2小时前

半日主力资金加仓煤炭、银行股,抛售电子股

主力资金早间净流入煤炭、银行、公用事业等板块,净流出电子、机械设备、计算机等板块。具体到个股来看,常山北明、永泰能源、利通电子获净流入16.29亿元、8.81亿元、6.68亿元。净流出方面,中兴通讯、岩山科技、中芯国际遭抛售6.92亿元、4.97亿元、4.92亿元。(第一财经)

2小时前

阿里国际站:欧洲投入显成效,外贸旺季第一周法国市场大涨109%

36氪获悉,进入3月外贸旺季,全球最大的B2B跨境电商平台阿里国际站上,法国市场订单量同比大涨109%,同时整个欧洲也都在快速增长。此前,阿里国际站推出“八先过海”计划,全年对欧洲市场双倍投入,帮中国商家开拓市场,抢先出海。今年3月以来,不仅是欧洲,阿里国际站上美国市场也增长稳健,中东、亚太等新兴市场涌现更多新热点,作为出海的第一站,阿里国际站在外贸旺季的火爆,显示出当下出海热潮在向更多市场延伸。

2小时前

本页详细列出关于上海医药的品牌信息,含品牌所属公司介绍,上海医药所处行业的品牌地位及优势。
咨询